Schistosomiasis affects 200 million individuals in underdeveloped and developing regions
and is a growing concern for travelers worldwide. There has been evidence of resistance to …

Chemotherapy based on repeated doses of praziquantel remains the most effective control
strategy against schistosomiasis, a neglected tropical disease caused by platyhelminths of …

Praziquantel has remained the drug of choice for schistosomiasis chemotherapy for almost
40 years. The pressing need to develop a new antischistosomal drug may necessitate …

Schistosomiasis is a chronic parasitic disease affecting about 207 million people in the
world. It still represents a major health problem in many tropical and sub-tropical countries …

Schistosomiasis, or bilharzias, is a neglected disease that remains a considerable public
health problem in tropical and subtropical regions. This parasitic disease is the most …

Since no vaccine exists against schistosomiasis and the molluscs acting as intermediate
hosts are not easy to attack, chemotherapy is the main approach for schistosomiasis control …

Schistosomiasis is a chronic parasitic disease in tropical and subtropical regions and is
associated with a variety of clinical syndromes that may lead to severe morbidity. Over the …

A schistosome genome project was initiated by the World Health Organization in 1994 with
the notion that the best prospects for identifying new targets for drugs, vaccines, and …

Schistosomiasis is a debilitating neglected tropical disease caused by schistosome worms.
Global efforts to control schistosomiasis rely predominantly on mass drug administration of …

Schistosomiasis, a grave and debilitating disease of socioeconomic importance, is
increasing in incidence despite concerted efforts to control and contain the disease in all the …